Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.

about

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.

Item

http://www.wikidata.org/entity/Q55433054

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@en

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@nl

type

Item

label

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@en

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@nl

prefLabel

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@en

Pharmacokinetic comparison of ...... ign in healthy adult subjects.

@nl

P1476

Pharmacokinetic comparison of ...... sign in healthy adult subjects

@en

P2093

Eun-Young Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Gook Shin

http://www.w3.org/2001/XMLSchema#string

Minkyung Oh

http://www.w3.org/2001/XMLSchema#string

Sung-Eun Park

http://www.w3.org/2001/XMLSchema#string

P2860

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Comparative bioavailability cf two amlodipine formulation in healthy volunteers.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.

The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease.

Bioequivalence approaches for highly variable drugs and drug products.

Evaluation of a scaling approach for the bioequivalence of highly variable drugs.

P304

1157-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S164215

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jong-Lyul Ghim

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29780236

http://www.w3.org/2001/XMLSchema#string

P921

replicability

P932

5951219

http://www.w3.org/2001/XMLSchema#string